Surgery of Ebstein anomaly  by Chauvaud, S.
emphasize that stenting can be an effective
mode of treatment of persistent coronary
artery and graft vasospasm.
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Surgery of Ebstein anomaly
To the Editor:
I read with great interest the article by
Quinonez and colleagues1 concerning sur-
gical treatment of the Ebstein anomaly.
This very informative article underlines the
role of the right ventricle in the outcome of
this congenital anomaly. As my colleagues
and I2 pointed out almost 10 years ago,
impairment of the right ventricle is a major
prognostic factor after surgery for the Eb-
stein anomaly. Inasmuch as medical ther-
apy is difficult to manage, it seemed to us
that the association of a bidirectional cavo-
pulmonary shunt (BCPS) would be helpful
in the early follow-up period. This contin-
ues to be our policy.
The term used by the authors, “1.5-
ventricle,” does not seem to me to be ade-
quate. The flow of the superior vena cava
varies between one third and one half of the
cardiac ouput.3 The 1.5-ventricle concept is
valid when one of the ventricles is anatom-
ically partially deficient.
The article by Quinonez and associates
does not answer a question that arises im-
mediately: what are the indications for the
BCPS? Their definition of “failing right
ventricle” is not clear. In their series, 2
children were free of symptom, whereas,
on the other hand, 3 adult patients were on
the transplantation list. Right ventricular
enlargement could be an indicator, but we
are still looking for quantitative data. In a
study of the right and left ventricular vol-
umes before and after surgery, my col-
leagues and I4 were unable to determine a
threshold value for patients “at risk” and
those that were “safe.” In our experience, a
large atrialized right ventricle (even if ex-
cluded after surgery), a very thin infundib-
ular right ventricular wall, and/or a para-
doxic septal motion are indications for a
superior vena cava derivation. Among 105
patients with Ebstein repair and BPCS, we
did not observe any deleterious effect of
the shunt except for a transient swelling of
the neck in 1 patient.
The BCPS does not solve all of the left
and right ventricular problems. One of the
patients in the authors’ series is not im-
proved and 2 in our own series had to
undergo transplantation.
However, the associated anastomosis is
an excellent additional procedure in pa-
tients with difficult indications.
S. Chauvaud, MD
Cardiovascular Surgery Department
Hôpital Européen Georges Pompidou
Paris, France
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Reply to the Editor:
My colleagues and I thank Dr Chauvaud
for his comments and acknowledge the
contribution of his team to the surgical
treatment of Ebstein anomaly.
The use of the term “1.5-ventricle” was
a semantic choice used to represent an op-
eration, rather than a quantitative or phys-
iologic descriptor. It is widely understood
that diversion of blood flow by a bidirec-
tional cavopulmonary shunt (BCPS) varies
from one third to one half of the systemic
venous return, depending on the patient’s
age.
To decide when to construct a BCPS,
the surgeon has to use his or her judgment
and experience and take into consideration
the patient’s clinical condition, echocardio-
graphic data, magnetic resonance imaging
data (if available), preoperative and intra-
operative hemodynamic data, and the intra-
operative morphologic appearance of the
right ventricle. The status of the left ven-
tricle is also very important. Our series is
too limited to advise as to the specific in-
dications of a BCPS in Ebstein anomaly,
yet with further experience and follow-up
these will become apparent. It is our im-
pression that it is only needed in a few
selected cases.
The term “failing right ventricle” is de-
liberately general. It may describe a right
ventricle that cannot sustain the circulation
after cardiopulmonary bypass; it may de-
scribe a right ventricle that is severely dys-
functional or dilated on echocardiography,
magnetic resonance imaging, or intraoper-
ative inspection; or it may describe a right
ventricle with a large atrialized component,
a thin wall, and paradoxical septal motion,
as pointed out by Dr Chauvaud. In any of
these circumstances, the patient may be
free of symptoms. The underlying diffi-
culty arises in the precise quantification of
right ventricular function by the currently
available methods. We are exploring the
use of magnetic resonance imaging to bet-
ter describe and quantitate the morphology
and function of the right ventricle.
Luis G. Quinonez, MD
University of Alberta Hospital
Edmonton, Alberta, Canada
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The conduct of experimental
circulatory arrest: The search for
clinical relevance
To the Editor:
I read with great interest the excellent
laboratory study by Dr Ananiadou and
colleagues1 detailing the neuroprotective
effect of profound hypothermia at 10°C
after 75 minutes of circulatory arrest in
an acute porcine model (N  12). The
described neuroprotective mechanism
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